Maliheh Gharibshahian

Maliheh Gharibshahian

Auto-generated profile, based on publicly available information

Maliheh Gharibshahian

Department of Tissue Engineering and Applied Cell Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2024 in Skin Research and Technology
Verified
Journal Article
Open access
MGMaliheh Gharibshahian
Maliheh Gharibshahian
MTMohammad Torkashvand
Mohammad Torkashvand
MBMahya Bavisi
Mahya Bavisi
NANiloofar Aldaghi
Niloofar Aldaghi
AAAkram Alizadeh
Akram Alizadeh
Background: Tissue engineering and regenerative medicine (TERM) aim to repair or replace damaged or lost tissues or organs due to accidents, diseases, or aging, by applying different sciences. For this purpose, an essential part of TERM is the designing, manufacturing, and evaluating of scaffolds, cells, tissues, and organs. Artificial intelligence (AI) or the intelligence of machines or software can be effective in all areas where computers play a role. Methods: The “artificial intelligence,” “machine learning,” “tissue engineering,” “clinical evaluation,” and “scaffold” keywords used for searching in various databases and articles published from 2000 to 2024 were evaluated. Results: The combination of tissue engineering and AI has created a new generation of technological advancement in the biomedical industry. Experience in TERM has been refined using advanced design and manufacturing techniques. Advances in AI, particularly deep learning, offer an opportunity to improve scientific understanding and clinical outcomes in TERM. Conclusion: The findings of this research show the high potential of AI, machine learning, and robots in the selection, design, and fabrication of scaffolds, cells, tissues, or organs, and their analysis, characterization, and evaluation after their implantation. AI can be a tool to accelerate the introduction of tissue engineering products to the bedside. Highlights: The capabilities of artificial intelligence (AI) can be used in different ways in all the different stages of TERM and not only solve the existing limitations, but also accelerate the processes, increase efficiency and precision, reduce costs, and complications after transplantation. ML predicts which technologies have the most efficient and easiest path to enter the market and clinic. The use of AI along with these imaging techniques can lead to the improvement of diagnostic information, the reduction of operator errors when reading images, and the improvement of image analysis (such as classification, localization, regression, and segmentation).

29 June 2023 in Journal of Biological Engineering
Verified
Journal Article
Open access
PDF file
MFMohammad Kamalabadi Farahani
Mohammad Kamalabadi Farahani
MGMaliheh Gharibshahian
Maliheh Gharibshahian
ARAlireza Rezvani
Alireza Rezvani
AVAhmad Vaez
Ahmad Vaez
Currently, breast carcinoma is the most common form of malignancy and the main cause of cancer mortality in women worldwide. The metastasis of cancer cells from the primary tumor site to other organs in the body, notably the lungs, bones, brain, and liver, is what causes breast cancer to ultimately be fatal. Brain metastases occur in as many as 30% of patients with advanced breast cancer, and the 1-year survival rate of these patients is around 20%. Many researchers have focused on brain metastasis, but due to its complexities, many aspects of this process are still relatively unclear. To develop and test novel therapies for this fatal condition, pre-clinical models are required that can mimic the biological processes involved in breast cancer brain metastasis (BCBM). The application of many breakthroughs in the area of tissue engineering has resulted in the development of scaffold or matrix-based culture methods that more accurately imitate the original extracellular matrix (ECM) of metastatic tumors. Furthermore, specific cell lines are now being used to create three-dimensional (3D) cultures that can be used to model metastasis. These 3D cultures satisfy the requirement for in vitro methodologies that allow for a more accurate investigation of the molecular pathways as well as a more in-depth examination of the effects of the medication being tested. In this review, we talk about the latest advances in modeling BCBM using cell lines, animals, and tissue engineering methods.

22 November 2024 in Heliyon
Verified
Journal Article
Open access
EGElaheh Gharibshahian
Elaheh Gharibshahian
MGMaliheh Gharibshahian
Maliheh Gharibshahian
MTMajid Jafar Tafreshi
Majid Jafar Tafreshi
MBMarjan Bahraminasab
Marjan Bahraminasab
SASamaneh Arab
Samaneh Arab
KTiOPO4 (KTP) nanoparticles (NPs) are potential materials as biolabels for long-term imaging. Optimizing their properties can lead to higher imaging efficiency and lower cytotoxicity and side effects. In this study, these nanoparticles were synthesized using the co-precipitation method and capping agents of oxalic acid and glycine. The capping agent's effect on the structural, optical, morphological, hemocompatibility, and biocompatibility properties of the obtained nanoparticles was studied. The smallest (12.56 nm) grain size and the lowest lattice strain (0.0024) were obtained using 1:1 and 1:3 mol ratios of glycine, respectively. Oxalic acid as a capping agent resulted in needle-type, flower-type, and oval-form NPs. Polygonal tablet form, cubic, and polyhedral forms of KTP NPs were synthesized using glycine. C–O–H bending bonds, O–H, N–H, and carbonyl (C=O) stretching bonds remain on the surface of synthesized NPs after heat treatment and functionalization of their surface. Our results showed that the surface functionalization modifies the biocompatibility properties of NPs. The 1:3 mol ratio of oxalic acid as a capping agent resulted in the perfect KTP NPs for long-term imaging studies. The presence of hydroxyl groups improved the biocompatibility of obtained KTP NPs using a 1:3 mol ratio of oxalic acid over time. The needle form of obtained NPs resulted in an increase in cell cytotoxicity at higher concentrations.